Frontiers in Aging Neuroscience (Jan 2024)
Fish oil supplementation, physical activity and risk of incident Parkinson’s disease: results of longitudinal analysis from the UK Biobank
- Fabin Lin,
- Fabin Lin,
- Fabin Lin,
- Fabin Lin,
- Fabin Lin,
- Yisen Shi,
- Yisen Shi,
- Yisen Shi,
- Yisen Shi,
- Jiayi Zheng,
- Jiayi Zheng,
- Jiayi Zheng,
- Jiayi Zheng,
- Yueping Li,
- Yueping Li,
- Yueping Li,
- Xuanjie Chen,
- Xinyang Zou,
- Xinyang Zou,
- Yi Hong,
- Ke Chen,
- Ke Chen,
- Ke Chen,
- Ke Chen,
- Yuqi Zeng,
- Yuqi Zeng,
- Yuqi Zeng,
- Qinyong Ye,
- Qinyong Ye,
- Qinyong Ye,
- Xiaochun Chen,
- Xiaochun Chen,
- Xiaochun Chen,
- Xinyan Chen,
- Xinyan Chen,
- Xinyan Chen,
- Yingqing Wang,
- Yingqing Wang,
- Yingqing Wang,
- Guoen Cai,
- Guoen Cai,
- Guoen Cai
Affiliations
- Fabin Lin
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Fabin Lin
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Fabin Lin
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Fabin Lin
- School of Basic Medical Science, Fujian Medical University, Fuzhou, China
- Fabin Lin
- Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China
- Yisen Shi
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Yisen Shi
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Yisen Shi
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Yisen Shi
- School of Basic Medical Science, Fujian Medical University, Fuzhou, China
- Jiayi Zheng
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Jiayi Zheng
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Jiayi Zheng
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Jiayi Zheng
- School of Basic Medical Science, Fujian Medical University, Fuzhou, China
- Yueping Li
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Yueping Li
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Yueping Li
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Xuanjie Chen
- School of Basic Medical Science, Fujian Medical University, Fuzhou, China
- Xinyang Zou
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Xinyang Zou
- School of Basic Medical Science, Fujian Medical University, Fuzhou, China
- Yi Hong
- School of Basic Medical Science, Fujian Medical University, Fuzhou, China
- Ke Chen
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Ke Chen
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Ke Chen
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Ke Chen
- School of Basic Medical Science, Fujian Medical University, Fuzhou, China
- Yuqi Zeng
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Yuqi Zeng
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Yuqi Zeng
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Qinyong Ye
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Qinyong Ye
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Qinyong Ye
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Xiaochun Chen
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Xiaochun Chen
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Xiaochun Chen
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Xinyan Chen
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Xinyan Chen
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Xinyan Chen
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Yingqing Wang
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Yingqing Wang
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Yingqing Wang
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- Guoen Cai
- Department of Neurology, Institute of Clinical Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China
- Guoen Cai
- Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China
- Guoen Cai
- Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China
- DOI
- https://doi.org/10.3389/fnagi.2023.1304629
- Journal volume & issue
-
Vol. 15
Abstract
ObjectiveEvidence on the individual and combined relationship of physical activity (PA) and fish oil supplement use on the incidence of Parkinson’s disease (PD) risk remains lacking.Materials and methodsThis UK population-based prospective cohort study, involving 385,275 UK Biobank participants, collected PA and fish oil supplement data via touchscreen questionnaires. Using Cox proportional hazards models and restricted cubic splines to examined the associations between use of fish oil supplements, PA and PD risk.ResultsDuring a median 12.52-year follow-up, 2,131 participants incident PD. Analysis showed that fish oil supplement users had a lower PD risk [hazard ratio (HR), 0.89; 95% confidence interval (CI), 0.82–0.98]. The adjusted HRs for the PD incidence were 0.96 (95% CI, 0.95–0.98) for total PA; 0.93 (95% CI, 0.90–0.96) for moderate PA; 0.95 (95% CI, 0.91–0.99) for vigorous PA and 0.93 (95% CI, 0.89–0.98) for walking activity. Significant interactions were found between fish oil supplement use and total PA (P for interaction = 0.011), moderate PA (P for interaction = 0.015), and walking activity (P for interaction = 0.029) in relation to PD incidence.ConclusionBoth fish oil supplement use and PA were associated with a reduced risk of PD, and the effect of PA in reducing the risk of PD was more pronounced when fish oil supplement was used.
Keywords